TY - JOUR
T1 - Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system
AU - Albo, Daniel
AU - Berger, David H.
AU - Wang, Thomas N.
AU - Hu, Xiaolong
AU - Rothman, Vicki
AU - Tuszynski, George P.
N1 - Funding Information:
Supported in part by National CA65675 and CA69722 (G.P.T). Dr. Bergrr is a recipient of an American Cancer Society Clinical Career Development Award 96-09. Presented at the Fifty-eighth Annual Meeting of the Society of University Surgeons, Tampa, Fla., Feb. 13-15, 1997. Reprint requests: George P. Tuszynski, PhD, Department of Surgery, Allegheny University of the Health Sciences, Broad and Vine Sts., Mail Stop 435, Philadelphia, PA 19102. Copyright 0 1997 by Mosby-Year Book, Inc.
PY - 1997/8
Y1 - 1997/8
N2 - Background. Pericellular proteolysis is crucial in tumor cell invasion. The plasminogen/plasmin system is one of the main protease systems involved in cancer progression. Thrombospondin-1 (TSP-1), through activation of transforming growth factor-β1 (TGF-β1), up-regulates the main plasminogen activator, the urokinase-type plasminogen activator (uPA). The objectives of this study were to determine the role of TSP-1 and TGF-β1 in the localization of the plasminogen/plasmin system to the tumor cell surface by the uPA receptor (uPAR) and to determine its effect in breast tumor cell invasion. Methods. The effect of TSP-1 and TGF-β1 in uPAR expression was determined in MDA-MB-231 human breast cancer cells by enzyme-linked immunosorbent assay and Western blot analysis. Their effect and the role of the plasminogen/plasmin system in breast tumor cell invasion were studied with a Boyden Chamber assay. Results. uPAR expression was up-regulated more than twofold by both TSP-1 and TGF-β1. The effect of TSP-1 involved its receptor and the activation of TGF-β1 by TSP-1. Breast tumor cell invasion was up-regulated sevenfold to eightfold by both TSP-1 and TGF-β1 compared with the control group. Antibodies against uPA or uPAR neutralized the TSP- 1-and TGFβ1-promoted breast tumor cell invasion. Conclusions. TSP-1, through the activation of endogenous TGF-β1, up-regulates the plasminogen/plasmin system and promotes tumor cell invasion in breast cancer cells.
AB - Background. Pericellular proteolysis is crucial in tumor cell invasion. The plasminogen/plasmin system is one of the main protease systems involved in cancer progression. Thrombospondin-1 (TSP-1), through activation of transforming growth factor-β1 (TGF-β1), up-regulates the main plasminogen activator, the urokinase-type plasminogen activator (uPA). The objectives of this study were to determine the role of TSP-1 and TGF-β1 in the localization of the plasminogen/plasmin system to the tumor cell surface by the uPA receptor (uPAR) and to determine its effect in breast tumor cell invasion. Methods. The effect of TSP-1 and TGF-β1 in uPAR expression was determined in MDA-MB-231 human breast cancer cells by enzyme-linked immunosorbent assay and Western blot analysis. Their effect and the role of the plasminogen/plasmin system in breast tumor cell invasion were studied with a Boyden Chamber assay. Results. uPAR expression was up-regulated more than twofold by both TSP-1 and TGF-β1. The effect of TSP-1 involved its receptor and the activation of TGF-β1 by TSP-1. Breast tumor cell invasion was up-regulated sevenfold to eightfold by both TSP-1 and TGF-β1 compared with the control group. Antibodies against uPA or uPAR neutralized the TSP- 1-and TGFβ1-promoted breast tumor cell invasion. Conclusions. TSP-1, through the activation of endogenous TGF-β1, up-regulates the plasminogen/plasmin system and promotes tumor cell invasion in breast cancer cells.
UR - http://www.scopus.com/inward/record.url?scp=0030868422&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030868422&partnerID=8YFLogxK
U2 - 10.1016/S0039-6060(97)90043-X
DO - 10.1016/S0039-6060(97)90043-X
M3 - Article
C2 - 9288157
AN - SCOPUS:0030868422
SN - 0039-6060
VL - 122
SP - 493
EP - 500
JO - Surgery (United States)
JF - Surgery (United States)
IS - 2
ER -